Company intelligence / Profile preview

Chymia

Durham, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

Chymia is a Duke University biotechnology spinout formed in February 2021 to commercialize therapeutics and biomarkers for neuropsychiatric disorders and related diseases. The company appears to be focused on translating Duke-originated precision psychiatry and metabolomics research into new venture-backed product companies and programs. Publicly available information indicates that Chymia participated in the formation of PsyProtix with atai Life Sciences to develop precision psychiatry approaches for treatment-resistant depression and other mental health indications. Based on the limited disclosed pipeline information, Chymia looks to be an early-stage private platform biotech centered on biomarker-enabled CNS innovation rather than a broadly disclosed clinical-stage drug developer.

Therapeutic areas: PsychiatryNeurology
Modalities: BiologicBiomarker
Industry: Biotech

Partnerships

atai Life SciencesDuke UniversityPsyProtix

Beyond the preview

Go deeper on Chymia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chymia.

Explore the full profile